Aspergillus fumigatus is an opportunistic fungal pathogen causing detrimental infections in immunocompromised individuals. Dendritic cells (DCs) are potent antigen-presenting cells and recognize the A. fumigatus cell wall component β-1,3 glucan via Dectin-1, followed by DC maturation and cytokine release. Here, we demonstrate that human primary myeloid DCs (mDCs) interact with different morphotypes of A. fumigatus. Dectin-1 is expressed on mDCs and is down-regulated after contact with A. fumigatus, indicating that mDCs recognize A. fumigatus via this receptor. Blocking of Dectin-1, followed by stimulation with depleted zymosan diminished the up-regulation of the T-cell co-stimulatory molecules CD40, CD80, HLA-DR and CCR7 on mDCs and led to decreased release of the cytokines TNF-α, IL-8, IL-1β and IL-10.
Introduction
Aspergillus fumigatus is an opportunistic pathogenic mould with a worldwide distribution. Hundreds of airborne fungal spores are inhaled daily into the human lung 1 and can cause detrimental infections particularly in immunocompromised individuals. 2 β-glucan is a major cell wall fraction of A. fumigatus with repeating glucose units connected by β-1,3 glycosidic linkages. Immune cells recognize β-glucan by Dectin-1, a member of the C-type lectin (CLR) family of pattern recognition receptors (PRRs). 3 Dectin-1 is expressed on a variety of immune cell populations, including monocytes, macrophages, neutrophils, a small subset of Tcells and monocyte-derived dendritic cells (moDCs). 4 DCs are the sentinels of the immune system by bridging innate and adaptive immune responses against pathogens. 5 They are potent antigen-presenting cells with the capability to induce immune responses by sensing pathogens, capturing antigens, and then migrating to the lymph nodes to stimulate T-cells. 6 For research purposes, human immature moDCs, which are generated in vitro from peripheral monocytes, are commonly used as a model system to study DC functions in vitro. 
Materials and methods

Isolation of mDCs
Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood of healthy volunteers, using Ficoll-Hypaque density gradient centrifugation (Biochrome AG). mDCs were isolated from PBMCs using paramagnetic beads of the Myeloid Dendritic Cell Isolation Kit (Miltenyi Biotech), according to manufacturer's instructions. This assay contains a depletion step of CD19+ cells as resting B cells also express the marker CD1c, followed by a positive selection of CD1c+ mDCs.
MDCs were used immediately after isolation, had a purity of >90% and did not contain any plasmacytoid DCs. All experiments were performed in RPMI 1640 medium (Invitrogen) supplemented with 10 % fetal calf serum (FCS, Sigma).
Fungal culture
A. fumigatus (ATCC 46645) conidia were cultivated on beer mash plates at 37
• C for 2-3 days. Then, endotoxinfree water was added, and conidia were harvested and singularized using a sterile cotton swab and a 40 μm nylon pore mesh cell strainer (Sigma). Conidial suspension was stored at 4
• C. Swollen conidia were produced by inoculating the resting conidia in RPMI medium and incubating the suspension for 4-5 h at 37
• C and 200 rpm. For germination, conidia were shaken at 200 rpm for 5-6 h at 37
• C under occasional surveillance.
Analysis of Dectin-1 regulation and mDC maturation
To investigate the expression of Dectin-1 on mDCs, cells were stained with a monoclonal anti-human Dectin-1 PE conjugated antibody (clone no. 259931; R&D Systems) or IgG2b (R&D Systems) as an isotype control. Expression of Dectin-1 was analyzed after 1, 3 and 6 h of confrontation with A. fumigatus conidia (con), swollen conidia (sc), or germ tubes (gt) at a multiplicity of infection (MOI) of 1. Maturation of mDCs was analyzed by flow cytometry after 18 h of stimulation with A. fumigatus conidia (MOI = 1) or the commercially available ultrapure Dectin-1 ligand depleted zymosan. Zymosan depleted is a Saccharomyces cerevisiae cell wall preparation treated with hot alkali to remove all its TLR-stimulating properties (100 μg/ml, 13 endotoxin levels <0.001 EU/μg, InvivoGen). The following monoclonal antibodies or their corresponding isotype controls were used: anti-CD80-APC (Miltenyi Biotec), anti-CD83-PE (BD), anti-CD86-FITC (BD), anti-CD40-FITC (BD), anti-HLA-DR-PE (BD), anti-CCR7-APC (Miltenyi Biotec). Fluorescence was measured using a FACS Calibur, and data were analyzed using the CellQuest Pro (BD) and FlowJo (Tree Star) software.
Blocking studies
For Dectin-1 blocking studies, 5 × 10 5 mDCs were pre-incubated for 15 min with human FcR Blocking Reagent (Miltenyi Biotec), followed by incubation for 1 h with anti-hDectin-1-IgG (clone no. 22H8, 10 μg/ml; InvivoGen). Thereafter, mDCs were stimulated for 18 h with A. fumigatus conidia (MOI = 1) or 100 μg/ml depleted zymosan, respectively.
Cytokine quantification
After stimulation of mDCs with conidia (MOI = 1) or 100 μg/ml depleted zymosan for 18 h, levels of tumor necrosis factor-α (TNF-α), interleukin-8 (IL-8), IL-1β and IL-10 were quantified by commercially available sandwich ELISA assays according to manufacturer's protocol (BioLegend).
Statistics
For calculation of significance, P-values were evaluated by two-tailed, unpaired Student t-test using MS Excel (Microsoft). Statistical significance is indicated with asterisks as follows:
* P < .05, * * P < .01, * * * P < .001.
Results
Dectin-1 was differentially regulated on mDCs dependent on the presence of different fungal morphotypes
Initial experiments focused on elucidating if Dectin-1 surface expression is specifically regulated after confrontation of primary human mDCs with different A. fumigatus morphotypes. Dectin-1 was expressed and remained unchanged on unstimulated mDCs over time (Fig. 1) . However, Dectin-1 was markedly down-regulated in the presence of resting conidia, swollen conidia, and germ tubes after 1, 3, and 6 h of co-cultivation. As Dectin-1 is known to be down-regulated after ligand binding, these data indicate that mDCs bind to all three fungal morphotypes via Dectin-1, followed by subsequent down-regulation of the receptor on the cell surface for at least 6 h, compared to unstimulated mDCs.
Blocking of Dectin-1 diminished the expression of maturation markers on mDCs
To further confirm the involvement of Dectin-1 in fungal recognition by primary human mDCs, the expression of the maturation-associated molecules CD40, CD80, HLA-DR, and CCR7 was monitored on the surface of mDCs. Stimulation of mDCs with swollen conidia of A. fumigatus or with depleted zymosan (an ultrapure Dectin-1 ligand) for 18 h induced the expression of co-stimulatory molecules (CD40, CD80, HLA-DR) and the homing receptor CCR7 compared to unstimulated mDCs (Fig. 2) . In contrast, blocking of Dectin-1 by using an anti-Dectin-1 blocking antibody prior to stimulation of Dectin-1 with depleted zymosan suppressed the up-regulation of the co-stimulatory molecules and CCR7 markedly, compared to unblocked cells. These data further confirm the involvement of the Dectin-1 pathway in fungal-induced mDC maturation.
Blocking of Dectin-1 inhibited mDC cytokine release
Besides the expression of T-cell stimulatory molecules, the release of specific cytokines (including TNF-α, IL-8, and IL-1β) is an essential function of mDCs to effectively induce a Th1 response. To assess the relevance of Dectin-1 expression on mDC-mediated cytokine release, blocking of Dectin-1, followed by stimulation with A. fumigatus conidia or depleted zymosan and subsequent collection of culture supernatants was performed. Both stimuli significantly increased the secretion of the proinflammatory cytokines TNF-α, IL-8, and IL-1β as well as of the anti-inflammatory cytokine IL-10 from unblocked mDCs (Fig. 3) . However, blocking of Dectin-1 and subsequent stimulation of mDCs with A. fumigatus conidia or depleted zymosan led to markedly lower levels of TNF-α, IL-8, IL-1β, and IL-10 compared to unblocked mDCs. These results demonstrate that Dectin-1 is involved in cytokine release of mDCs after fungal stimulation and support the hypothesis that this receptor is pivotal in the recognition of A. fumigatus and the subsequent activation of mDCs. 
Discussion
DCs play an important role in the human host defense against pathogenic fungi as they are involved in the initiation of both, innate and adaptive immune responses.
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After antigen uptake, DCs mature and upregulate T-cell costimulatory molecules. 14 This antigen uptake is mediated among others by C-type lectin receptors, including Dectin-1. 15 Here, we provide evidence that the Dectin-1 pathway is pivotal for the recognition of A. fumigatus and the induction of a pro-inflammatory response in human mDCs. Most often, for research purposes, human immature moDCs are used in in vitro experiments, as they are readily and numerously available. They are generated in vitro by culturing monocytes with IL-4 and granulocytemacrophage colony stimulating factor for several days. Knowledge on the role of DCs in anti-A. fumigatus immune responses was mainly deduced from experiments with moDCs. However, moDCs not necessarily show the same biological behavior, stimulatory capability and pattern recognition receptors compared to mDCs, which are primary cells directly isolated from peripheral blood. As an example, moDCs phagocytose more A. fumigatus conidia and germ tubes than mDCs, and they express significantly less class I and class II MHCs than mDCs and plasmacytoid DCs (pDC). 12 Recently, Joo et al. demonstrated that Dectin-1 ligation activates pDCs, using synthetic receptor agonists such as R848, CpG-B, or curdlan, which is a water-insoluble beta-1.3 glucan isolated from the soil bacterium Alcaligenes faecalis. 16 However, in contrast to synthetic molecular patterns, cell wall polysaccharide composition varies, dependent on the fungal morphotype. 17 Thus, we sought to analyze whether Dectin-1 stimulation activates mDCs and if the stimulation depends on different A. fumigatus morphotypes, as described previously for moDCs and other myeloid phagocytes. 18 In our previous study, we were able to show that Dectin-1 is an important receptor for A. fumigatus on moDCs and that it is involved in the induction of a pro-inflammatory cytokine response. 7 Dectin-1 silencing on moDCs by RNAi leads to significantly decreased cytokine production. 7 In this present study, we confirmed that also mDCs interact with distinct A. fumigatus morphotypes via Dectin-1. Interestingly, Dectin-1 blocking on mDCs followed by stimulation with depleted zymosan, a pure Dectin-1 ligand and lacking TLR-binding capacity, led to diminished maturation and cytokine release of mDCs. In parallel, in moDCs which were stimulated with depleted zymosan, Dectin-1 blocking led to diminished induction of the expression of CD40, CD80, HLA-DR, and CCR7 as well (data not shown).
Cytokine release from mDCs upon Dectin-1 specific stimulation with depleted zymosan was significantly diminished after Dectin-1 blocking. Thus, and in parallel to former reports with moDCs, 7 we were able to confirm the immunomodulatory role for Dectin-1 also for mDCs. In summary, this study confirms that Dectin-1 is involved in the recognition of A. fumigatus on primary human mDCs and contributes to their immunomodulatory capacity. This is of special relevance as mDCs, in contrast to the "artificial" moDCs exist in the human body and directly interact with T-cells initiating T-cell crosspriming, and the generation of potent CTL responses. Furthermore, mDCs orchestrate the innate immune system by releasing IL-1β, IL-8, IL-10, and TNF-α, subsequent to Dectin-1 stimulation. In the future, mDCs might be used as vaccines or adjuvants. TLR agonists but also ultrapure β-glucans are attractive adjuncts for DC vaccines due to their critical role in regulating lymphocyte homeostasis and potentiating T-cell function. 23 Thereby, depleted zymosan plays a crucial role as Dectin-1 stimulation is characterized by robust production of cytokines, driving Th1 and Th17 responses.
